James Redenbarger
Nessuna posizione attualmente
Profilo
Jim Redenbarger has been Vice President of Operations since joining QLT, Inc. in 2004.
Most recently, he was a Principal at Growth Management Consulting.
Previously, he was Vice President of Operations at Synergen.
He has more than 25 years of experience in pharmaceuticals, devices and biotechnology.
Mr. Redenbarger received a BS in Microbiology from Purdue University.
Precedenti posizioni note di James Redenbarger
| Società | Posizione | Fine |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Direttore operativo | - |
Formazione di James Redenbarger
| Purdue University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
- Borsa valori
- Insiders
- James Redenbarger
